Nuvectis Pharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Nuvectis Pharma's balance sheet done over the years? Its assets were worth $19,185,000 last year, which is less than in the previous period. 36% of Nuvectis Pharma’s total assets is currently financed by debt. Its liabilities reached the amount of $6,984,000, which means an increase by 13% compared compared to last year.
Debt to Assets
| 2020 | 0 | 10K | Infinity% |
|---|---|---|---|
| 2021 | 6657000 | 17.66M | 265.36% |
| 2022 | 20405000 | 6.18M | 30.32% |
| 2023 | 19185000 | 6.98M | 36.4% |
NVCT Balance Sheet (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 19.12M | 19.99M | 5.74M | 0 |
Short term investments | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 |
Other current assets | 59K | 412K | 91K | 0 |
Total current assets | 19.18M | 20.40M | 5.83M | 0 |
Non-current assets: | ||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 |
Other non-current assets | 0 | 0 | 824K | 0 |
Total non-current assets | 0 | 0 | 824K | 0 |
Total assets | 19.18M | 20.40M | 6.65M | 0 |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 0 | 0 | 0 | 0 |
Short term debt | 0 | 0 | 0 | 0 |
Total current liabilities | 6.98M | 6.18M | 2.41M | 10K |
| Non-current liabilities: | ||||
Long term debt | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 0 |
Total non-current liabilities | 0 | 2.91M | 15.24M | 0 |
Total liabilities | 6.98M | 6.18M | 17.66M | 10K |
| Data source | Data source | Data source |